Testing effectiveness (Phase 2)UnknownNCT04156958
What this trial is testing
Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma
Who this might be right for
Biliary Tract Adenocarcinoma
Sichuan University 33
Showing 20 of 0 results